Update | June 2021: UKRI Research England funding ended in June 2021. Whilst we no longer provide opportunities to progress technologies through Grow MedTech, we are still committed to delivering learning and developing opportunities through Translate until the end of the year.
We have nurtured a vibrant network of academics, companies, clinicians and patients. Our grants scheme provides funding for key points in the technology development process, to help academics take their ideas forward. We have supported companies looking to progress their technologies, by providing expertise, creating partnerships and access to funding. And we aimed to ensure the technologies developed were better aligned to patient needs, by involving them at every stage of the journey.
Through our partner programme, Translate, we still provide opportunities for our network to learn from each other, through training workshops and secondments.
Explore our graphic to find out more
Grow your medtech network
We act as partnership brokers, using our knowledge and experience to proactively connect people from academia, industry and clinical practice to ...Read more
Grow your medtech idea
With a Grow MedTech technology innovation manager based at each of our partner universities, we provide academics with in-house support and resources ...Read more
Grow your medtech knowledge
Through our partner project Translate, academics and researchers from the Leeds City Region can access a targeted innovation development ...Read more
Grow your medtech business
We provide companies with access to a pool of academic and clinical expertise across the region, to underpin their development of medical technologies.Read more
Grow your patient involvement
Our ambition is to help develop medical technologies that are better aligned to patient needs by involving patients and people with long-term ...Read more
If you’d like to receive information on future opportunities and events and news from the medtech community, sign up using our form or simply send us a query and we will reply as quickly as possible.